MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Inogen Langfristige Verbindlichkeiten 2011-2026 | INGN
Langfristige Verbindlichkeiten Jährlich Inogen
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 52.5 M | 18.9 M | 14.1 M | 9.12 M | 5.28 M | 3.2 M | 6.43 M | 5.22 M | 7.43 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 52.5 M | 3.2 M | 13.6 M |
Langfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
1.61 M | $ 33.22 | 1.87 % | $ 1.47 B |  USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
1.33 M | $ 7.01 | 2.04 % | $ 503 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
1.1 M | $ 3.76 | -1.7 % | $ 130 M | USA |
 |
Alphatec Holdings
ATEC
|
89.9 M | $ 13.29 | 1.41 % | $ 1.9 B | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
Bio-Rad Laboratories
BIO
|
1.35 B | $ 255.19 | -12.51 % | $ 7.2 B | USA |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 36.35 | -3.09 % | $ 5.42 K | USA |
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 41.59 | -0.28 % | $ 1.28 B | USA |
 |
Boston Scientific Corporation
BSX
|
11.8 B | $ 74.77 | 0.88 % | $ 110 B | USA |
 |
Abbott Laboratories
ABT
|
25.7 B | $ 112.22 | 0.66 % | $ 195 B | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 4.8 | 0.63 % | $ 179 M |  France |
 |
Delcath Systems
DCTH
|
2.52 M | $ 9.25 | 1.43 % | $ 264 M | USA |
 |
Cutera
CUTR
|
430 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
23.9 M | $ 13.44 | 3.07 % | $ 363 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 24.2 | 3.82 % | $ 205 M | USA |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Dynatronics Corporation
DYNT
|
10 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
161 M | - | - | $ 10.2 M | USA |
 |
InMode Ltd.
INMD
|
12 M | $ 14.36 | 0.38 % | $ 1.14 B | Israel |
 |
IRadimed Corporation
IRMD
|
4.76 M | $ 99.81 | -0.03 % | $ 1.26 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.02 B | $ 85.46 | 0.23 % | $ 2.87 B | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Penumbra
PEN
|
89.2 M | $ 339.82 | 0.32 % | $ 13.1 B | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
36.4 M | $ 18.55 | 0.05 % | $ 122 M | USA |
 |
Pulmonx Corporation
LUNG
|
25 M | $ 1.47 | 3.17 % | $ 57.5 M | USA |
 |
Globus Medical
GMED
|
18.2 M | $ 87.89 | 0.76 % | $ 11.9 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.56 B | $ 11.29 | 4.46 % | $ 869 M | USA |
 |
Myomo
MYO
|
275 K | $ 0.82 | 0.41 % | $ 5.78 M | USA |
 |
Establishment Labs Holdings
ESTA
|
53.7 M | $ 75.22 | 2.28 % | $ 2.12 B |  Costa-rica |